Article Information
History
- November 8, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- 1Department of Pathology, Brigham and Women’s Hospital, Boston, MA
- 2Department of Systems Biology, Harvard Medical School, Boston, MA
- 3Ludwig Center at Harvard, Boston, MA
- ↵*Corresponding author: Ashwini Jambhekar, PhD, Department of Systems Biology, Harvard Medical School, 210 Longwood Avenue, Armenise 605A, Boston, MA 02115, Phone: (617) 432-9091, ashwini_jambhekar{at}hms.harvard.edu
Posted November 08, 2024.
Detection of TP53 mutations by IHC in acute myeloid leukemia varies with interpreter expertise and mutation status
